Syphilis Clinical Trial
Official title:
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis Syphilis Ab Test at the Point- Of-Care Sites
This study is a prospective cross-sectional study in which surgically non-invasive sample- taking is done only for the purpose of the study. Capillary (fingerstick) whole blood and plasma (i.e., obtained through venous EDTA whole blood collection and processing) are collected by a healthcare professional. The collected samples are tested in a routine testing environment, i.e., healthcare providers at
A trained healthcare provide will collect 50μL of capillary whole blood and 11mL of EDTA venous whole blood (VWB) to be tested with the iStatis Syphilis Ab Test on site according to the 'Test Procedure' described in the Instructions for Use (IFU) supplied with the reagents. Same procedure must be followed using the extracted plasma sample to test 30μL of the plasma sample extracted and obtained through processing of the VWB on the iStatis Syphilis Ab Test. An aliquot of the plasma sample will be transferred to the central laboratory to establish the reference test result using an enzyme immunoassay (EIA) (Abbott Architect Syphilis Tp EDA). In case of positive results in the EIA reference test of (Abbott Architect Syphilis Tp EDA), the sample will be sent for BD Macro-Vue Particle Agglutination (RPR) and Serodia Particle Agglutination (TPPA) testing. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03660488 -
Cefixime for Alternative Syphilis Treatment
|
Phase 2 | |
| Recruiting |
NCT05548426 -
Linezolid for Syphilis Pilot Study
|
Phase 2 | |
| Not yet recruiting |
NCT05951751 -
The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)
|
N/A | |
| Completed |
NCT02191527 -
Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique
|
N/A | |
| Completed |
NCT01439503 -
Safer Sex Program for Young African-American Men
|
Phase 2 | |
| Completed |
NCT02257658 -
Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM
|
N/A | |
| Terminated |
NCT01540227 -
Penicillin Therapeutic Drug Monitoring in the Treatment of Infectious Syphilis.
|
||
| Completed |
NCT02611765 -
Syphilis Response to Higher Penicillin Dosage: The 2.4 Versus 7.2 Study
|
Phase 4 | |
| Completed |
NCT03709862 -
Global Syphilis Sequencing
|
||
| Completed |
NCT03637660 -
Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection
|
Phase 4 | |
| Active, not recruiting |
NCT03310424 -
Transcriptomic and Next Generation Sequencing Approaches to Infection With Treponema Pallidum
|
||
| Completed |
NCT00207506 -
Lay Health Advisors for Sexually Transmitted Disease Prevention
|
Phase 1/Phase 2 | |
| Completed |
NCT00213018 -
Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
|
Phase 2 | |
| Recruiting |
NCT06059443 -
mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention
|
N/A | |
| Completed |
NCT04480749 -
Syphilis Self-testing to Expand Test Uptake Among Men Who Have Sex With Men (SST)
|
Phase 4 | |
| Not yet recruiting |
NCT06058286 -
MENJAGA: Continuous Quality Improvement for Antenatal HIV, Syphilis and Hepatitis B Testing in Indonesia
|
N/A | |
| Active, not recruiting |
NCT03980223 -
Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men
|
Phase 4 | |
| Completed |
NCT01465607 -
Implementation of an Efficacious Intervention for High Risk Women in Mexico
|
N/A | |
| Completed |
NCT00553111 -
Video Tool to Promote Knowledge of Syphilis as Facilitator of HIV Transmission
|
N/A | |
| Active, not recruiting |
NCT06367621 -
Retrospective Study of iStatis Syphilis Ab Test (POC)
|